Kelly Lawrence W & Associates Inc Edwards Lifesciences Corp Transaction History

Kelly Lawrence W & Associates Inc

$430 Million
Q3 2024

A detailed history of Kelly Lawrence W & Associates Inc transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Kelly Lawrence W & Associates Inc holds 11,325 shares of EW stock, worth $839,409. This represents 0.17% of its overall portfolio holdings.

Number of Shares

11,325

Previous 11,865 4.55%

Holding current value

$839,409

Previous $1.1 Million 31.78%

% of portfolio

0.17%

Previous 0.26%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$59.7 - $93.78 $32,238 - $50,641	-540 Reduced 4.55%	11,325 $747,000
Q2 2024 Aug 13, 2024	SELL	$84.3 - $94.31 $42,150 - $47,155	-500 Reduced 4.04%	11,865 $1.1 Million
Q1 2024 May 15, 2024	SELL	$72.54 - $95.56 $64,197 - $84,570	-885 Reduced 6.68%	12,365 $1.18 Million
Q2 2023 Aug 14, 2023	SELL	$81.41 - $94.33 $64,313 - $74,520	-790 Reduced 5.63%	13,250 $1.25 Million
Q1 2023 May 15, 2023	SELL	$74.26 - $84.51 $65,720 - $74,791	-885 Reduced 5.93%	14,040 $1.16 Million
Q4 2022 Feb 14, 2023	SELL	$68.3 - $87.44 $163,920 - $209,856	-2,400 Reduced 13.85%	14,925 $1.11 Million
Q3 2022 Nov 15, 2022	SELL	$82.37 - $107.29 $453,035 - $590,095	-5,500 Reduced 24.1%	17,325 $1.43 Million
Q2 2022 Aug 15, 2022	SELL	$86.5 - $128.27 $21,625 - $32,067	-250 Reduced 1.08%	22,825 $2.17 Million
Q1 2022 May 16, 2022	SELL	$101.96 - $128.34 $305,880 - $385,020	-3,000 Reduced 11.51%	23,075 $2.72 Million
Q1 2021 May 17, 2021	BUY	$78.68 - $90.67 $1.11 Million - $1.28 Million	14,150 Added 118.66%	26,075 $2.18 Million
Q4 2020 Feb 12, 2021	SELL	$71.69 - $91.23 $1.13 Million - $1.44 Million	-15,825 Reduced 57.03%	11,925 $1.09 Million
Q3 2020 Nov 13, 2020	SELL	$67.19 - $87.44 $7.02 Million - $9.14 Million	-104,550 Reduced 79.02%	27,750 $2.22 Million
Q2 2020 Aug 14, 2020	BUY	$57.54 - $76.95 $5.08 Million - $6.79 Million	88,200 Added 200.0%	132,300 $9.14 Million
Q1 2020 May 14, 2020	SELL	$52.41 - $81.0 $262,049 - $405,000	-5,000 Reduced 10.18%	44,100 $8.32 Million
Q1 2018 May 15, 2018	SELL	$37.19 - $47.45 $119,008 - $151,840	-3,200 Reduced 6.12%	49,100 $6.85 Million
Q4 2017 Feb 14, 2018	BUY	$33.79 - $39.39 $172,329 - $200,889	5,100 Added 10.81%	52,300 $5.9 Million
Q3 2017 Nov 15, 2017	BUY	$36.29 - $38.83 $1.71 Million - $1.83 Million	47,200	47,200 $5.16 Million

Others Institutions Holding EW

# of Institutions

1,350

Shares Held

456M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $45.8B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kelly Lawrence W & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Kelly Lawrence W & Associates Inc with notifications on news.

Account

Kelly Lawrence W & Associates Inc Edwards Lifesciences Corp Transaction History